Navigation Links
2009 Prix Galien USA Now Accepting Nominations for Top Prize in Biopharmaceutical Research and Development
Date:3/11/2009

NEW YORK, March 11 /PRNewswire-USNewswire/ -- The committee responsible for awarding the most prestigious prize in biopharmaceutical research and development -- Prix Galien USA -- announced it is accepting 2009 nominations. For the first time, the committee will include a new recognition category for best medical device. It also has expanded the eligibility window to the past decade.

Prix Galien USA is now awarded in three categories that offer broad implications for future biomedical research: best pharmaceutical agent, best biotechnology product and best medical device. All pharmaceutical and biological drugs or devices approved by the U.S. Food and Drug Administration for first or new indications between 1998 and 2008 are eligible for nomination in 2009. This new eligibility period will permit the judges to determine both the immediate and the long-term impact these pharmaceuticals, biotechnology products and devices have had on human health and disease.

"The Prix Galien USA committee is delighted to be able to honor the impact medical devices have on human health," said Gerald Weissmann, M.D., Prix Galien USA committee chair, research professor of medicine at New York University and editor-in-chief of The FASEB Journal. "When we consider how new pharmaceuticals, biotechnology products and devices have changed our lives, it is clear that we have entered a new era of medical discovery."

The committee, which includes six Nobel Laureates, will honor the ingenuity of the biopharmaceutical industry at its annual gala event on September 30 at the American Museum of Natural History in New York. Online nominations for Prix Galien USA 2009 are being accepted through June 1st http://submission.prix-galien-usa.com.

Selzentry(TM) (Pfizer Inc.), Isentress(R) (Merck & Co., Inc.), Soliris(R) (Alexion Pharmaceuticals, Inc.), INFUSE(R) (Wyeth) and Revlimid(R) (The Celgene Corporation) were recognized by the Prix Galien USA committee in 2008 for applications that address pervasive illness and diseases.

The Prix Galien Award recognizes technical, scientific and clinical research skills necessary to develop innovative medicines and devices, and is considered the industry's highest accolade -- equivalent to the Nobel Prize. The Prix Galien USA award committee comprises 11 individuals including Nobel Laureates, founders of major biotech companies and editors of world-renowned biology journals. For details about the Prix Galien USA award and committee visit www.prix-galien-usa.com.


'/>"/>
SOURCE Prix Galien Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Prix Galien USA Welcomes Eighth Nobel Laureate to its Prestigious Award Committee
2. Prix Galien USA Recognizes Biotech, Pharmaceutical Industries for Innovative Medical Treatments
3. Inspiring Authors Tell Inspirational Stories: Special Writers Find Accepting Home at Lulu.com
4. PA Governors Occupational Safety and Health Conference Still Accepting Registrations
5. UIC College of Nursing in Peoria Now Accepting Applications for New Doctorate of Nursing Practice
6. Joint Commission, National Quality Forum Now Accepting Applicants for the 2008 John M. Eisenberg Patient Safety and Quality Awards
7. Gates Foundation Now Accepting Proposals for Grand Challenges Explorations
8. SEIU RN Dian Palmer Calls on AFL-CIO Head John Sweeney to Review Video From Dearborn Protest, Retract Statement Accepting CNA Distortions
9. American Sentinel University Accepting Enrollment in Online RN to BS in Nursing
10. American Pain Society Accepting Applications for Clinical Centers of Excellence in Pain Management Awards
11. PRN Funding Now Accepting Credit Cards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... ... 2016 , ... The International Yoga Teacher Training schoo l will ... close to the town famous for its sunsets, Oia. This all inclusive yoga training ... have an amazing experience in Greece, we just can’t stay away” says Co-Founder Carri ...
(Date:5/6/2016)... ... May 06, 2016 , ... Few events in healthcare ... mostly for its cost despite its potential to wipe out a silent killer, ... of a class called direct-acting antivirals (DAAs)—have created fallout in the courts and ...
(Date:5/6/2016)... ... 2016 , ... “ Crossing Over: Affirmations of Faith in the Midst of ... allowed those holding vigil to glimpse into the supernatural as their lives ended. With ... spiritually and practically gain insight into providing care to terminal patients. , “I ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... in the industry’s gold standard KLAS Performance Report, Epic Consulting 2016 ... assessed organizations that specialize in consulting services for electronic health record (EHR) solutions ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... Einstein ... dedicated Twitter feed to cover the latest news and commentary at the 2016 ASCRS/ASOA ... This meeting of the American Society of Cataract and Refractive Surgery and the American ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... 3, 2016   BIOTRONIK , a leader ... Food and Drug Administration (FDA) approval of Iperia ... heart failure patients with access to diagnostic magnetic ... remote monitoring with daily automatic transmission and closed ... in response to physiological demands. ...
(Date:5/3/2016)... , May 3, 2016   BIOTRONIK will ... extending care beyond the implant at the Heart Rhythm ... in San Francisco . ... the highest quality of patient care and satisfaction possible. ... for each and every tomorrow," said Marlou Janssen ...
(Date:5/3/2016)... , May 3, 2016 Pharmaceutical ... $55 million to a woman who says its talc-based ... awarded Gloria Ristesund $5 million in compensatory ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ... against the company. In February, the same court awarded ...
Breaking Medicine Technology: